.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Farmers Insurance
McKesson
Queensland Health
McKinsey
Colorcon
Cantor Fitzgerald
Argus Health
Daiichi Sankyo
AstraZeneca

Generated: November 21, 2017

DrugPatentWatch Database Preview

DESFERAL Drug Profile

« Back to Dashboard

Which patents cover Desferal, and when can generic versions of Desferal launch?

Desferal is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.

Pharmacology for DESFERAL

Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity

Medical Subject Heading (MeSH) Categories for DESFERAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
DESFERAL
deferoxamine mesylate
INJECTABLE;INJECTION016267-002May 25, 2000APRXYesYes► Subscribe► Subscribe► Subscribe
Novartis
DESFERAL
deferoxamine mesylate
INJECTABLE;INJECTION016267-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DESFERAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
DESFERAL
deferoxamine mesylate
INJECTABLE;INJECTION016267-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Express Scripts
UBS
Queensland Health
Dow
Cerilliant
Baxter
US Army
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot